Table 3 Demographic and Clinical Characteristics of Study Subjects
From: Automated external cardioversion defibrillation monitoring in cardiac arrest: a randomized trial
AECD n = 95 | Control n = 97 | P Value | |
|---|---|---|---|
Age ± SD | 61.7 ± 3.4 | 62 ± 3.4 | 0.7 |
Gender | 0.98 | ||
Male | 92 (96.8%) | 94 (96.9%) | |
Female | 3 (3.2%) | 3 (3.1%) | |
Race | 0.15 | ||
Hispanic | 2 (2.1%) | 0 | |
White | 42 (44.2%) | 53 (54.6%) | |
Black | 51 (53.7%) | 44 (45.4%) | |
History of HF | 25 (26.3%) | 20 (20.6%) | 0.39 |
New Diagnosis of HF | 6 (6.3%) | 4 (4.1%) | 0.53 |
Diabetes mellitus | 46 (48.4%) | 35 (36.1%) | 0.11 |
History of CAD | 35 (36.8%) | 42 (43.3%) | 0.38 |
Hypertension | 79 (84%) | 74 (76.3%) | 0.28 |
Hyperlipidemia | 55 (57.9%) | 53 (54.6%) | 0.66 |
EKG on admission | 0.62 | ||
NSR | 84 (88.4%) | 81 (83.5%) | |
Atrial fibrillation/flutter | 9 (9.5%) | 11 (11.3%) | |
SVT | 0 | 2 (2.1%) | |
Other | 2 (2.1%) | 3 (3.1%) |